Vera Therapeutics (VERA) Net Equity Issued and Repurchased (2021 - 2022)
Vera Therapeutics (VERA) posted Net Equity Issued and Repurchased of $86.1 million for Q1 2022, up 268.3% on a QoQ basis from -$51.2 million in Q4 2021.
Vera Therapeutics (VERA) Net Equity Issued and Repurchased (2021 - 2022) Analysis & Trends
Vera Therapeutics' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $86.1 million for Q1 2022.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $86.1 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $86.1 million (changed N/A YoY) and the FY2022 annual result came in at $2.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was $86.1 million for Q1 2022 at Vera Therapeutics, up from -$51.2 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $86.1 million in Q1 2022 and bottomed at -$51.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 86.13 Mn |
| Mar 31, 2022 | 86.13 Mn |
| Dec 31, 2021 | -51.18 Mn |
| Dec 31, 2021 | -51.18 Mn |
| Jun 30, 2021 | 51.18 Mn |
| Jun 30, 2021 | 51.18 Mn |